Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yuki Matsuoka is a pioneering robotic surgeon whose work bridges thoracic and urologic oncology, with a focus on minimally invasive techniques that improve patient outcomes. His landmark 2012 case report on robotic bronchoplastic lobectomy for lung cancer (29 citations) demonstrated the feasibility of complex airway reconstruction using a three-arm robotic system, establishing a foundation for advanced robotic thoracic surgery. In urology, Dr. Matsuoka has made significant contributions to prostate cancer management, including identifying predictive factors for pathological downgrading in patients with biopsy Gleason score 4+3 or 4+4 disease (5 citations)—work that refines risk stratification and treatment planning. His research on urethrovesical anastomotic leakage following robot-assisted laparoscopic prostatectomy (7 citations) provides critical insights into postoperative recovery and continence outcomes. Most recently, Dr. Matsuoka examined the impact of the COVID-19 pandemic on robot-assisted radical prostatectomy practices (2 citations), highlighting how global health crises shape surgical decision-making. With over 43 total citations across these key studies, his work continues to influence robotic surgical protocols and patient care standards, particularly in the integration of advanced robotics for both lung and prostate cancer surgeries.